Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme.
Saved in:
| Title: | Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme. |
|---|---|
| Authors: | Danese, Silvio1 (AUTHOR) sdanese@hotmail.com, Subramaniam, Kavitha2 (AUTHOR), Van Zyl, Jan3 (AUTHOR), Adsul, Shashi4 (AUTHOR), Lindner, Dirk4 (AUTHOR), Roth, Jeannine4 (AUTHOR), Vermeire, Séverine5 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jan2021, Vol. 53 Issue 2, p265-272. 8p. 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.16160 |